You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 5, 2024

CLINICAL TRIALS PROFILE FOR FIRAZYR

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for FIRAZYR

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00912093 ↗	A Study of Icatibant in Patients With Acute Attacks of Hereditary Angioedema (FAST-3)	Completed	Shire	Phase 3	2009-07-16	This study is being conducted to evaluate the efficacy and safety of icatibant compared to placebo in patients experiencing acute attacks of hereditary angioedema (HAE).
NCT00997204 ↗	EASSI - Evaluation of the Safety of Self-Administration With Icatibant	Completed	Jerini AG	Phase 3	2009-09-25	This study is being conducted to explore the clinical safety, local tolerability, convenience and effectiveness of self-treatment of hereditary angioedema (HAE) attacks with subcutaneous injections of icatibant.
NCT00997204 ↗	EASSI - Evaluation of the Safety of Self-Administration With Icatibant	Completed	Shire	Phase 3	2009-09-25	This study is being conducted to explore the clinical safety, local tolerability, convenience and effectiveness of self-treatment of hereditary angioedema (HAE) attacks with subcutaneous injections of icatibant.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for FIRAZYR

Condition Name

Chart
Table

Condition Name for FIRAZYR
Intervention	Trials
Hereditary Angioedema	3
Hereditary Angioedema (HAE)	2
COVID-19 Pneumonia	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for FIRAZYR
Intervention	Trials
Angioedema	7
Angioedemas, Hereditary	5
COVID-19	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for FIRAZYR

Trials by Country

Map
Table

Trials by Country for FIRAZYR
Location	Trials
United States	76
Canada	6
Australia	6
France	5
Israel	4
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for FIRAZYR
Location	Trials
California	7
Pennsylvania	5
Texas	4
Maryland	4
Ohio	3
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for FIRAZYR

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for FIRAZYR
Clinical Trial Phase	Trials
Phase 4	2
Phase 3	4
Phase 2	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for FIRAZYR
Clinical Trial Phase	Trials
Completed	6
Recruiting	2
Terminated	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for FIRAZYR

Sponsor Name

Chart
Table

Sponsor Name for FIRAZYR
Sponsor	Trials
Shire	6
Northwestern University	1
Wake Forest University Health Sciences	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for FIRAZYR
Sponsor	Trials
Other	26
Industry	9
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.